Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dong M Shin

Showing results (51-60 of 253) with videos related to

Pageof 26
Sort By:
ACS Nano|September 25, 2010
A reexamination of active and passive tumor targeting by using rod-shaped gold nanocrystals and covalently conjugated peptide ligandsXiaohua Huang, Xianghong Peng, Yiqing Wang, et al.
Translational Cancer Research|February 12, 2026
Survival and response outcomes in patients with recurrent/metastatic head and neck cancer treated with opioids and statins: an exploratory pilot studyElihu Igbinadolor, Tyler J Kristoff, Dong M Shin, et al.
Plos Genetics|June 2, 2015
Canine spontaneous head and neck squamous cell carcinomas represent their human counterparts at the molecular levelDeli Liu, Huan Xiong, Angela E Ellis, et al.
Head & Neck|August 9, 2005
Neoadjuvant chemotherapy for squamous cell carcinoma of the oral tongue in young adults: a case seriesErich M Sturgis, Brian A Moore, Bonnie S Glisson, et al.
Head & Neck|December 17, 2008
Examining expression of folate receptor in squamous cell carcinoma of the head and neck as a target for a novel nanotherapeutic drugNabil F Saba, Xu Wang, Susan Müller, et al.
International Journal of Nanomedicine|November 11, 2008
Targeted magnetic iron oxide nanoparticles for tumor imaging and therapyXiang-Hong Peng, Ximei Qian, Hui Mao, et al.
Clinical Lung Cancer|January 12, 2017
Association of Cytoplasmic CXCR4 With Loss of Epithelial Marker and Activation of ERK1/2 and AKT Signaling Pathways in Non-Small-Cell Lung CancerNabil F Saba, Yuxiang Wang, Hongpeng Fu, et al.
Nanotechnology|May 13, 2009
Quantum dot-based quantification revealed differences in subcellular localization of EGFR and E-cadherin between EGFR-TKI sensitive and insensitive cancer cellsDong-Hai Huang, Ling Su, Xiang-Hong Peng, et al.
Head & Neck|April 29, 2009
Sequence dependence of cell growth inhibition by EGFR-tyrosine kinase inhibitor ZD1839, docetaxel, and cisplatin in head and neck cancerCarmen M Klass, Mi Sun Choe, Selwyn J Hurwitz, et al.
The Laryngoscope|October 27, 2020
Parenteral Bevacizumab for the Treatment of Severe Respiratory Papillomatosis in an Adult PopulationAndrew Tkaczuk, Sumita Trivedi, Mayur D Mody, et al.
Pageof 26

Showing results (51-60 of 253) with videos related to

Sort By:
Pageof 26
ACS Nano|September 25, 2010
A reexamination of active and passive tumor targeting by using rod-shaped gold nanocrystals and covalently conjugated peptide ligandsXiaohua Huang, Xianghong Peng, Yiqing Wang, et al.
Translational Cancer Research|February 12, 2026
Survival and response outcomes in patients with recurrent/metastatic head and neck cancer treated with opioids and statins: an exploratory pilot studyElihu Igbinadolor, Tyler J Kristoff, Dong M Shin, et al.
Plos Genetics|June 2, 2015
Canine spontaneous head and neck squamous cell carcinomas represent their human counterparts at the molecular levelDeli Liu, Huan Xiong, Angela E Ellis, et al.
Head & Neck|August 9, 2005
Neoadjuvant chemotherapy for squamous cell carcinoma of the oral tongue in young adults: a case seriesErich M Sturgis, Brian A Moore, Bonnie S Glisson, et al.
Head & Neck|December 17, 2008
Examining expression of folate receptor in squamous cell carcinoma of the head and neck as a target for a novel nanotherapeutic drugNabil F Saba, Xu Wang, Susan Müller, et al.
International Journal of Nanomedicine|November 11, 2008
Targeted magnetic iron oxide nanoparticles for tumor imaging and therapyXiang-Hong Peng, Ximei Qian, Hui Mao, et al.
Clinical Lung Cancer|January 12, 2017
Association of Cytoplasmic CXCR4 With Loss of Epithelial Marker and Activation of ERK1/2 and AKT Signaling Pathways in Non-Small-Cell Lung CancerNabil F Saba, Yuxiang Wang, Hongpeng Fu, et al.
Nanotechnology|May 13, 2009
Quantum dot-based quantification revealed differences in subcellular localization of EGFR and E-cadherin between EGFR-TKI sensitive and insensitive cancer cellsDong-Hai Huang, Ling Su, Xiang-Hong Peng, et al.
Head & Neck|April 29, 2009
Sequence dependence of cell growth inhibition by EGFR-tyrosine kinase inhibitor ZD1839, docetaxel, and cisplatin in head and neck cancerCarmen M Klass, Mi Sun Choe, Selwyn J Hurwitz, et al.
The Laryngoscope|October 27, 2020
Parenteral Bevacizumab for the Treatment of Severe Respiratory Papillomatosis in an Adult PopulationAndrew Tkaczuk, Sumita Trivedi, Mayur D Mody, et al.
Pageof 26